Stay updated with breaking news from நியூட்ரா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Neutra Corp: Neutra to Target Baby Boomers in Home Health and Hospice Care Bid KATY, TX / ACCESSWIRE / May 19, 2021 / Neutra Corp. (OTC PINK:NTRR) is closely examining options to enter the home health and hospice care business. The company believes the market offers a potentially sizeable opportunity for CBD products aimed at aging members of the Baby Boomer generation now retiring in large numbers. Recently retired Baby Boomers represent a great untapped source of customers and revenues for a CBD company like ours, said Neutra CEO Sydney Jim. As Baby Boomers reach retirement age, they re experiencing greater bodily pains and mental anxiety. CBD products can provide fast, inexpensive relief without the trouble of visiting a doctor. We re thinking that Baby Boomers, a generation that was never afraid to try new things, would welcome a high-potency, high-quality CBD option as part of their daily home health and hospice care to manage pain and overcome worry. ....
Neutra Corp: Houston-Area Wellness Center Nearly Sells Out of VIVIS Products During Launch Party KATY, TX / ACCESSWIRE / May 5, 2021 / Neutra Corp. (OTC PINK:NTRR) held a successful launch party May 1 at its newest retail partner s Houston-area store and reports the retailer sold nearly all of its initial order of VIVIS products to an enthusiastic crowd. The store, Restore Hyper Wellness, is already preparing to place a followup order for additional VIVIS products. Restore Hyper Wellness is located at 2715 Bissonnet St., Suite 140, just west of Kirby Dr. in the enclave city of West University Place. It s not far from Rice University. We had an outstanding event that exceeded all of our expectations, said Neutra CEO Sydney Jim. Shoppers were eager to sample and learn more about VIVIS and its offerings. When they learned about our commitment to quality and our stringent lab testing, customers starting grabbing everything we had to offer. We believe this is going to be ....
Neutra Corp: Neutra Nears Major International Agreement with Mexican Distributor for VIVIS CBD Manufactured Products KATY, TX / ACCESSWIRE / April 6, 2021 / Neutra Corp. (OTC PINK:NTRR) reports it s currently in negotiations with a Mexican company for distribution of VIVIS-manufactured CBD products throughout Mexico. When completed, the agreement will give Neutra and VIVIS an international presence just days after Neutra announced it had set a new company sales record in March 2021. This will open up an entirely new and exciting market for us, said Neutra CEO Sydney Jim. It represents a great opportunity to grow our manufacturing capabilities and introduce more people to the quality of VIVIS lab-tested CBD products. Combine this with our ongoing big box retail push and our recent sales success, and the rest of 2021 is looking quite promising for Neutra and its shareholders. ....
KATY, TX / ACCESSWIRE / March 15, 2021 / Neutra Corp. (OTC PINK:NTRR) subsidiary VIVIS is busy filling out vendor forms at two big box retailers, the first step towards being able to sell its hemp-based ....
Nutra Pharma Corporation: Nutra Pharma Engages Quality and Regulatory Professionals Ahead of Clinical Trials Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validation in preparation of expanded OTC sales and clinical trials Plantation, Florida (Newsfile Corp. - March 11, 2021) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, is providing updates today on their work in improving their existing facilities for manufacturing and validation of their drug products; including their technologies for the treatment of Multiple Sclerosis (MS) and potential countermeasures against nerve agents like sarin gas and VX. As part of this process, Nutra Pharma tod ....